Statements (63)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
government position
|
| gptkbp:advises |
public health issues
|
| gptkbp:advocatesFor |
patient safety
mental health awareness health equity |
| gptkbp:approves |
vaccines
|
| gptkbp:broadcasts |
food recalls
|
| gptkbp:collaborates_with |
academic institutions
|
| gptkbp:conducts |
scientific research
|
| gptkbp:coordinatesWith |
law enforcement agencies
emergency response teams international regulatory agencies |
| gptkbp:engagesIn |
public outreach
industry stakeholders patient advocacy groups |
| gptkbp:headquarters |
gptkb:Silver_Spring,_Maryland
|
| https://www.w3.org/2000/01/rdf-schema#label |
FDA Commissioner
|
| gptkbp:issuedBy |
gptkb:President_of_the_United_States
|
| gptkbp:issueFeePaid |
drug safety
public health threats |
| gptkbp:isUpdatedBy |
COVID-19 response
|
| gptkbp:leadership |
public health research.
|
| gptkbp:leads |
counterfeit drug prevention
|
| gptkbp:length |
indefinite
|
| gptkbp:manages |
drug approval process
clinical trial transparency foodborne illness outbreaks food safety modernization drug evaluation processes animal drug approvals |
| gptkbp:notableFeature |
tobacco products
drug shortages |
| gptkbp:oversees |
gptkb:Food_and_Drug_Administration
food labeling regulations cosmetic regulations radiation-emitting products clinical laboratory regulations medical product safety |
| gptkbp:participatesIn |
public meetings
international health forums healthcare_policy_discussions |
| gptkbp:partnerships |
community organizations
|
| gptkbp:promotes |
public health initiatives
|
| gptkbp:provides |
clinical trials
telehealth services dietary guidelines nutritional supplements biologics food additives |
| gptkbp:providesInformationOn |
healthcare_legislation
|
| gptkbp:providesTrainingFor |
FDA_staff
|
| gptkbp:recalls |
unsafe products
|
| gptkbp:reportsTo |
gptkb:Secretary_of_Health_and_Human_Services
|
| gptkbp:respondsTo |
public health emergencies
|
| gptkbp:responsibleFor |
regulating food safety
regulating medical devices regulating pharmaceuticals |
| gptkbp:reviews |
new drug applications
medical device applications |
| gptkbp:safety |
unsafe drugs
|
| gptkbp:works_with |
non-profit organizations
state and local governments drug pricing issues |